Nucleophilicity of Oximes Based upon Addition to a Nitrilium <i>closo</i>-Decaborate Cluster by Dmitrii S. Bolotin (1953220)

“…Three types of oxime species, i.e., 4-morpholyl­carb­ami­doxime (hydroxy­guanidine), phenyl­acet­amidoxime and benzamidoxime (amidoximes), and cyclo­hexanone oxime and benzo­phenone oxime (ketoximes), react at room temperature with the 2-nitrilium <i>closo</i>-decaborate clusters, leading to 2-iminium <i>closo</i>-decaborates (14 examples; 57–94%). …”

Nucleophilicity of Oximes Based upon Addition to a Nitrilium <i>closo</i>-Decaborate Cluster by Dmitrii S. Bolotin (1953220)

“…Three types of oxime species, i.e., 4-morpholyl­carb­ami­doxime (hydroxy­guanidine), phenyl­acet­amidoxime and benzamidoxime (amidoximes), and cyclo­hexanone oxime and benzo­phenone oxime (ketoximes), react at room temperature with the 2-nitrilium <i>closo</i>-decaborate clusters, leading to 2-iminium <i>closo</i>-decaborates (14 examples; 57–94%). …”

Muscle-specific knockdown of <i>nSMase</i> minimally decreases glucosylceramide levels, which are globally elevated in <i>Gba1b</i> mutants. by Kathryn A. Jewett (3756811)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

17β-estradiol (E₂) combined with anti-AGE treatment pyridoxamine (Pyr) increases ER and decreases TGF mRNA in glomeruli of aged ovariectomized female mice. by Simone Pereira-Simon (325005)

Periodicity of IgE. by Hiromi Yamaguchi (2396248)

Recombinant SFRP3 decreases migration and invasion of melanoma cells. by Elin J. Ekström (225100)

Lung and heart eNOS and iNOS mRNA. by Devi Ganesh (3176385)

Increasing the diversity of host resistance decreases the probability of evolutionary emergence. by Hélène Chabas (3194250)

Poor maternal nutrition decreases the oxidative phosphorylation capacity of offspring mesenchymal stem cells. by Sambhu M. Pillai (3394907)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…(<b>B</b>) Isoginkgetin treatment increases the “guillotine” base height (<i>p</i> = 10⁻¹²) of intronic expression without increasing the blade height (<i>p</i> = 0.5), consistent with a splicing defect (compare to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone-0089673-g001" target="_blank">Fig. 1A</a>). …”

HAI-2 deficiency leads to decreased proliferation of intestinal epithelium. by Roman Szabo (138655)

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Plakoglobin decreases <i>in vitro</i> cell growth and proliferation. by Zackie Aktary (481667)

Decreased neutrophil-mediated pathology in the liver of co-infected mice. by Kristen L. Lokken (558435)

Glutamate excitotoxicity decreases viability of cultured hippocampal GABAergic neurons. by Márcio S. Baptista (365618)

Decreased CSF cytokine levels in α7 KO mice. by Feng Chi (170688)

Inhibition of serine proteases decreases EndMTs and vascular calcification. by Pierre J. Guihard (3391721)

Berberine decreases IBMX- and FSK-induced CRE luciferase activity. by Juan Zhang (48597)